Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A model using hormone levels, cycle length, and BMI can help identify PCOS in Chinese women but isn't for screening teens.

Extracellular vesicles could revolutionize skincare by improving skin repair and anti-aging, but face regulatory and cost challenges.

m6A deregulation plays a key role in PCOS and could lead to new treatments.

Patchy hair loss can be an early sign of lupus.

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

Hormonal imbalances can cause hair loss, and understanding them can help develop better treatments.

A girl with type 1 diabetes developed a serious eye condition very early, suggesting the need for earlier eye checks and that early treatment can work well.

Hair organoids are effective for testing hair loss treatments.

Certain medications, including some immune drugs, contraceptives, and hair loss treatments, are often linked to hair loss.

New small molecule drugs could help treat hair loss.

Choosing the right starting dose of Clomiphene Citrate for ovulation induction in PCOS women is challenging; higher BMI and hormone levels may indicate resistance to the standard dose.

Alopecia Areata is linked to a higher risk of several diseases, which vary with age and sex.

Women with Polycystic Ovary Syndrome (PCOS) have a higher risk of developing type 2 diabetes due to insulin resistance.

Hair can naturally regain color, and stress might influence greying and its reversal.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

A toddler with unusual hypothyroidism symptoms improved with levothyroxine treatment.

Androgenetic alopecia is a long-term, immune-related disorder that starts during puberty due to androgen secretion, and it might be improved with iron tablets, platelet transfusion, and anti-inflammation therapy.

Hair specialists vary in testing for alopecia areata, highlighting the need for standard guidelines.

Five preservatives may disrupt hormone function and need more health and environmental risk assessment.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

A dog with a pituitary tumor developed tertiary hypothyroidism, improved with treatment, but was later euthanized due to neurological issues.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

Early diagnosis and hormone therapy can significantly improve outcomes for post-partum pituitary insufficiency in resource-limited settings.

Premature graying and hair changes can be treated with certain peptides and possibly targeting the endocannabinoid system.

Thyroid disorders, especially autoimmune ones, are very common in the studied group.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Most lab tests for patients with Telogen effluvium, a type of hair loss, show no or mild abnormalities; only a few specific tests are useful.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

A calf in Scotland likely had Schmallenberg virus from its mother.

Many women with hair loss also have zinc deficiency, iron depletion, or thyroid issues.